Comparative Bioavailability of a Generic and Two Compounded Naproxen Sodium Suspensions Administered to Rats

Bibliographic Details
Main Author: Araujo, Aurigena Antunes de
Publication Date: 2010
Other Authors: Solon, Lílian Grace da Silva, Guerra, Gerlane Bernardo Coelho, Barichello, José Mário, Pérez-Urizar, José, Soares, Luiz Alberto Lira
Format: Article
Language: por
Source: Repositório Institucional da UFRN
Download full: https://repositorio.ufrn.br/jspui/handle/123456789/25362
http://dx.doi.org/10.4172/1948-593X.1000021
Summary: The purpose of this study was to determine naproxen concentrations in rat plasma samples by HPLC and to compare the bioavailability of a generic and two compounded naproxen sodium suspensions (test 1 and test 2). Analysis was run at a fl ow rate of 1.2 mL.min -1 with a mobile phase of acetonitrile: NaH 2 PO 4 0.01 M pH 4.00 (50:50, v/v) at 280 nm, using a C 18 column (150 mm x 4.6 mm, 5 μ m). The calibration curve was linear (R 2 = 0.9987) over the range of 0.25 - 200 μ g.mL -1 . The precision for inter and intra-day analysis ranged from 2.46% to 12.39%. C max , T max and AUC t were 191.25 ± 11.17 μ g.mL -1 , 1.00 ± 0.106 h and 2438.16 ± 291.34 μ g.h.mL -1 for the reference drug, 188.22 ± 24.78 μ g.mL -1 , 1.06 ± 0.092 h and 1755.02 ± 228.90 μ g.h.mL -1 for test 1, and 160.50 ± 10.58 μ g.mL -1 , 0.66 ± 0.102 h and 1955.28 ± 142.80 μ g.h.mL -1 for test 2. No signi fi cant differences were found based on analysis of variance, with mean values and 90% CI of test2/reference ratio (C max 83.92% and AUC t 80.19%). For test1/reference ratio, the result was C max 98.41% and AUC t 71.98%. Based on these results, it can be concluded that the validated method was successfully applied to this study; the test 1 formulation failed to demonstrate a bioequivalence to the reference drug; however, the test 2 and reference naproxen sodium suspension were bioequivalent in terms of the rate and extent of absorption under these conditions.
id UFRN_37f7249ec5dedbddfba5b626d767326c
oai_identifier_str oai:https://repositorio.ufrn.br:123456789/25362
network_acronym_str UFRN
network_name_str Repositório Institucional da UFRN
repository_id_str
spelling Araujo, Aurigena Antunes deSolon, Lílian Grace da SilvaGuerra, Gerlane Bernardo CoelhoBarichello, José MárioPérez-Urizar, JoséSoares, Luiz Alberto Lira2018-06-12T15:16:40Z2018-06-12T15:16:40Z2010-04-23ARAUJO, Aurigena Antunes de; et al. Comparative Bioavailability of a Generic and Two Compounded Naproxen Sodium Suspensions Administered to Rats. Journal of Bioanalysis & Biomedicine, v. 2, p. 48-54, 2010. Disponível em: < https://www.omicsonline.org/comparative-bioavailability-of-a-generic-and-two-compounded-naproxen-sodium-suspensions-administered-to-rats-1948-593X.1000021.php?aid=336> Acesso em: 13 mar. 2018.1948-593Xhttps://repositorio.ufrn.br/jspui/handle/123456789/25362http://dx.doi.org/10.4172/1948-593X.1000021porJ Bioanal BiomedBioavailability studiesValidationHPLCPharmacokineticsCompounded naproxen sodium suspensionComparative Bioavailability of a Generic and Two Compounded Naproxen Sodium Suspensions Administered to Ratsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleThe purpose of this study was to determine naproxen concentrations in rat plasma samples by HPLC and to compare the bioavailability of a generic and two compounded naproxen sodium suspensions (test 1 and test 2). Analysis was run at a fl ow rate of 1.2 mL.min -1 with a mobile phase of acetonitrile: NaH 2 PO 4 0.01 M pH 4.00 (50:50, v/v) at 280 nm, using a C 18 column (150 mm x 4.6 mm, 5 μ m). The calibration curve was linear (R 2 = 0.9987) over the range of 0.25 - 200 μ g.mL -1 . The precision for inter and intra-day analysis ranged from 2.46% to 12.39%. C max , T max and AUC t were 191.25 ± 11.17 μ g.mL -1 , 1.00 ± 0.106 h and 2438.16 ± 291.34 μ g.h.mL -1 for the reference drug, 188.22 ± 24.78 μ g.mL -1 , 1.06 ± 0.092 h and 1755.02 ± 228.90 μ g.h.mL -1 for test 1, and 160.50 ± 10.58 μ g.mL -1 , 0.66 ± 0.102 h and 1955.28 ± 142.80 μ g.h.mL -1 for test 2. No signi fi cant differences were found based on analysis of variance, with mean values and 90% CI of test2/reference ratio (C max 83.92% and AUC t 80.19%). For test1/reference ratio, the result was C max 98.41% and AUC t 71.98%. Based on these results, it can be concluded that the validated method was successfully applied to this study; the test 1 formulation failed to demonstrate a bioequivalence to the reference drug; however, the test 2 and reference naproxen sodium suspension were bioequivalent in terms of the rate and extent of absorption under these conditions.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRNinstname:Universidade Federal do Rio Grande do Norte (UFRN)instacron:UFRNTEXTComparative Bioavailability of a Generic_2010.pdf.txtComparative Bioavailability of a Generic_2010.pdf.txtExtracted texttext/plain36439https://repositorio.ufrn.br/bitstream/123456789/25362/3/Comparative%20Bioavailability%20of%20a%20Generic_2010.pdf.txt619d7943196bb58001bbb5de068b99ceMD53THUMBNAILComparative Bioavailability of a Generic_2010.pdf.jpgComparative Bioavailability of a Generic_2010.pdf.jpgIM Thumbnailimage/jpeg9391https://repositorio.ufrn.br/bitstream/123456789/25362/4/Comparative%20Bioavailability%20of%20a%20Generic_2010.pdf.jpg8d428a87995c9d20e365b082e0ddea5fMD54TEXTComparative Bioavailability of a Generic_2010.pdf.txtComparative Bioavailability of a Generic_2010.pdf.txtExtracted texttext/plain36439https://repositorio.ufrn.br/bitstream/123456789/25362/3/Comparative%20Bioavailability%20of%20a%20Generic_2010.pdf.txt619d7943196bb58001bbb5de068b99ceMD53THUMBNAILComparative Bioavailability of a Generic_2010.pdf.jpgComparative Bioavailability of a Generic_2010.pdf.jpgIM Thumbnailimage/jpeg9391https://repositorio.ufrn.br/bitstream/123456789/25362/4/Comparative%20Bioavailability%20of%20a%20Generic_2010.pdf.jpg8d428a87995c9d20e365b082e0ddea5fMD54ORIGINALComparativeBioavailabilityGeneric_Araujo_2010.pdfComparativeBioavailabilityGeneric_Araujo_2010.pdfapplication/pdf1127861https://repositorio.ufrn.br/bitstream/123456789/25362/1/ComparativeBioavailabilityGeneric_Araujo_2010.pdff2a3f7cb6503a2508949583a898a1bc4MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://repositorio.ufrn.br/bitstream/123456789/25362/2/license.txt8a4605be74aa9ea9d79846c1fba20a33MD52123456789/253622021-11-11 17:21:25.422oai:https://repositorio.ufrn.br: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Repositório de PublicaçõesPUBhttp://repositorio.ufrn.br/oai/opendoar:2021-11-11T20:21:25Repositório Institucional da UFRN - Universidade Federal do Rio Grande do Norte (UFRN)false
dc.title.pt_BR.fl_str_mv Comparative Bioavailability of a Generic and Two Compounded Naproxen Sodium Suspensions Administered to Rats
title Comparative Bioavailability of a Generic and Two Compounded Naproxen Sodium Suspensions Administered to Rats
spellingShingle Comparative Bioavailability of a Generic and Two Compounded Naproxen Sodium Suspensions Administered to Rats
Araujo, Aurigena Antunes de
Bioavailability studies
Validation
HPLC
Pharmacokinetics
Compounded naproxen sodium suspension
title_short Comparative Bioavailability of a Generic and Two Compounded Naproxen Sodium Suspensions Administered to Rats
title_full Comparative Bioavailability of a Generic and Two Compounded Naproxen Sodium Suspensions Administered to Rats
title_fullStr Comparative Bioavailability of a Generic and Two Compounded Naproxen Sodium Suspensions Administered to Rats
title_full_unstemmed Comparative Bioavailability of a Generic and Two Compounded Naproxen Sodium Suspensions Administered to Rats
title_sort Comparative Bioavailability of a Generic and Two Compounded Naproxen Sodium Suspensions Administered to Rats
author Araujo, Aurigena Antunes de
author_facet Araujo, Aurigena Antunes de
Solon, Lílian Grace da Silva
Guerra, Gerlane Bernardo Coelho
Barichello, José Mário
Pérez-Urizar, José
Soares, Luiz Alberto Lira
author_role author
author2 Solon, Lílian Grace da Silva
Guerra, Gerlane Bernardo Coelho
Barichello, José Mário
Pérez-Urizar, José
Soares, Luiz Alberto Lira
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Araujo, Aurigena Antunes de
Solon, Lílian Grace da Silva
Guerra, Gerlane Bernardo Coelho
Barichello, José Mário
Pérez-Urizar, José
Soares, Luiz Alberto Lira
dc.subject.por.fl_str_mv Bioavailability studies
Validation
HPLC
Pharmacokinetics
Compounded naproxen sodium suspension
topic Bioavailability studies
Validation
HPLC
Pharmacokinetics
Compounded naproxen sodium suspension
description The purpose of this study was to determine naproxen concentrations in rat plasma samples by HPLC and to compare the bioavailability of a generic and two compounded naproxen sodium suspensions (test 1 and test 2). Analysis was run at a fl ow rate of 1.2 mL.min -1 with a mobile phase of acetonitrile: NaH 2 PO 4 0.01 M pH 4.00 (50:50, v/v) at 280 nm, using a C 18 column (150 mm x 4.6 mm, 5 μ m). The calibration curve was linear (R 2 = 0.9987) over the range of 0.25 - 200 μ g.mL -1 . The precision for inter and intra-day analysis ranged from 2.46% to 12.39%. C max , T max and AUC t were 191.25 ± 11.17 μ g.mL -1 , 1.00 ± 0.106 h and 2438.16 ± 291.34 μ g.h.mL -1 for the reference drug, 188.22 ± 24.78 μ g.mL -1 , 1.06 ± 0.092 h and 1755.02 ± 228.90 μ g.h.mL -1 for test 1, and 160.50 ± 10.58 μ g.mL -1 , 0.66 ± 0.102 h and 1955.28 ± 142.80 μ g.h.mL -1 for test 2. No signi fi cant differences were found based on analysis of variance, with mean values and 90% CI of test2/reference ratio (C max 83.92% and AUC t 80.19%). For test1/reference ratio, the result was C max 98.41% and AUC t 71.98%. Based on these results, it can be concluded that the validated method was successfully applied to this study; the test 1 formulation failed to demonstrate a bioequivalence to the reference drug; however, the test 2 and reference naproxen sodium suspension were bioequivalent in terms of the rate and extent of absorption under these conditions.
publishDate 2010
dc.date.issued.fl_str_mv 2010-04-23
dc.date.accessioned.fl_str_mv 2018-06-12T15:16:40Z
dc.date.available.fl_str_mv 2018-06-12T15:16:40Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv ARAUJO, Aurigena Antunes de; et al. Comparative Bioavailability of a Generic and Two Compounded Naproxen Sodium Suspensions Administered to Rats. Journal of Bioanalysis & Biomedicine, v. 2, p. 48-54, 2010. Disponível em: < https://www.omicsonline.org/comparative-bioavailability-of-a-generic-and-two-compounded-naproxen-sodium-suspensions-administered-to-rats-1948-593X.1000021.php?aid=336> Acesso em: 13 mar. 2018.
dc.identifier.uri.fl_str_mv https://repositorio.ufrn.br/jspui/handle/123456789/25362
dc.identifier.issn.none.fl_str_mv 1948-593X
dc.identifier.doi.none.fl_str_mv http://dx.doi.org/10.4172/1948-593X.1000021
identifier_str_mv ARAUJO, Aurigena Antunes de; et al. Comparative Bioavailability of a Generic and Two Compounded Naproxen Sodium Suspensions Administered to Rats. Journal of Bioanalysis & Biomedicine, v. 2, p. 48-54, 2010. Disponível em: < https://www.omicsonline.org/comparative-bioavailability-of-a-generic-and-two-compounded-naproxen-sodium-suspensions-administered-to-rats-1948-593X.1000021.php?aid=336> Acesso em: 13 mar. 2018.
1948-593X
url https://repositorio.ufrn.br/jspui/handle/123456789/25362
http://dx.doi.org/10.4172/1948-593X.1000021
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv J Bioanal Biomed
publisher.none.fl_str_mv J Bioanal Biomed
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRN
instname:Universidade Federal do Rio Grande do Norte (UFRN)
instacron:UFRN
instname_str Universidade Federal do Rio Grande do Norte (UFRN)
instacron_str UFRN
institution UFRN
reponame_str Repositório Institucional da UFRN
collection Repositório Institucional da UFRN
bitstream.url.fl_str_mv https://repositorio.ufrn.br/bitstream/123456789/25362/3/Comparative%20Bioavailability%20of%20a%20Generic_2010.pdf.txt
https://repositorio.ufrn.br/bitstream/123456789/25362/4/Comparative%20Bioavailability%20of%20a%20Generic_2010.pdf.jpg
https://repositorio.ufrn.br/bitstream/123456789/25362/3/Comparative%20Bioavailability%20of%20a%20Generic_2010.pdf.txt
https://repositorio.ufrn.br/bitstream/123456789/25362/4/Comparative%20Bioavailability%20of%20a%20Generic_2010.pdf.jpg
https://repositorio.ufrn.br/bitstream/123456789/25362/1/ComparativeBioavailabilityGeneric_Araujo_2010.pdf
https://repositorio.ufrn.br/bitstream/123456789/25362/2/license.txt
bitstream.checksum.fl_str_mv 619d7943196bb58001bbb5de068b99ce
8d428a87995c9d20e365b082e0ddea5f
619d7943196bb58001bbb5de068b99ce
8d428a87995c9d20e365b082e0ddea5f
f2a3f7cb6503a2508949583a898a1bc4
8a4605be74aa9ea9d79846c1fba20a33
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRN - Universidade Federal do Rio Grande do Norte (UFRN)
repository.mail.fl_str_mv
_version_ 1797777140925595648